GH Dividend: Guardant Health Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	902	739	563	449	373	286
Revenue Growth (YoY)	30%	31%	25%	20%	30%	34%
Cost of Revenue	327	289	227	155	122	92
Gross Profit	575	449	336	293	251	194
Selling, General & Admin	658	545	451	463	398	299
Research & Development	359	347	367	373	263	149
Operating Expenses	1,009	892	901	838	662	449
Other Non Operating Income (Expenses)	77	1	9	-99	0	4
Pretax Income	-397	-435	-478	-653	-384	-245
Income Tax Expense	1	1	0	1	0	0
Net Income	-398	-436	-479	-654	-405	-253
Net Income Growth	-22%	-9%	-27%	61%	60%	237%
Shares Outstanding (Diluted)	124.8	122.74	111.98	102.2	101.3	97.5
Shares Change (YoY)	1%	10%	10%	1%	4%	8%
EPS (Diluted)	-3.21	-3.55	-4.28	-6.41	-4	-2.6
EPS Growth	-23%	-17%	-33%	60%	54%	210%
Free Cash Flow	-262	-274	-345	-386	-284	-157
Free Cash Flow Per Share	-2.09	-2.23	-3.08	-3.77	-2.8	-1.61
Gross Margin	63.74%	60.75%	59.68%	65.25%	67.29%	67.83%
Operating Margin	-48%	-59.94%	-100.17%	-121.15%	-110.18%	-89.16%
Profit Margin	-44.12%	-58.99%	-85.07%	-145.65%	-108.57%	-88.46%
Free Cash Flow Margin	-29.04%	-37.07%	-61.27%	-85.96%	-76.13%	-54.89%
EBITDA	-393	-401	-522	-509	-389	-239
EBITDA Margin	-43.56%	-54.26%	-92.71%	-113.36%	-104.28%	-83.56%
D&A For EBITDA	40	42	42	35	22	16
EBIT	-433	-443	-564	-544	-411	-255
EBIT Margin	-48%	-59.94%	-100.17%	-121.15%	-110.18%	-89.16%
Effective Tax Rate	-0.25%	-0.22%	0%	-0.15%	0%	0%

Guardant Health Inc (GH) Price